Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  perillyl alcohol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-14 of 14 for your search:
Start Over
Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 0702-25, IRB # 0702-25, Clarian Values Grant: vfr-262, NCT00578279
Phase II Study of Perillyl Alcohol (POH) in Patients with Recurrent or Refractory Epithelial Ovarian Cancer (Summary Last Modified 05/2001)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-2E96, E2E96
Phase II Study of Perillyl Alcohol in Patients with Metastatic Adenocarcinoma of the Colon or Rectum (Summary Last Modified 01/2000)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-98202, NCI-T98-0044, T98-0044
Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000582634, P01CA027502, P30CA023074, UARIZ-HSC-04-27, UARIZ-POH-002, HSC #0427, NCT00608634
Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 9710-07; T98-0046, IUMC-9710-07, NCI-T98-0046, NCT00003769
Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066080, R21CA072500, WCCC-CO-9611, NCI-T97-0068, T97-0068, NCT00003219
Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000066113, R03CA073906, WCCC-CO-9685, NCI-T97-0067, T97-0067, NCT00003238
Phase I Study of Daily Oral Perillyl Alcohol for Advanced Solid Tumors (Summary Last Modified 02/98)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-9591, NCI-T95-0006H, T95-0006
Perillyl Alcohol in Treating Patients With Refractory Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: CDR0000065133, YALE-HIC-8895, NCI-T96-0064D, T96-0064, NCT00002862
Phase IA/IB Trial of Perillyl Alcohol in Patients with Refractory Solid Malignancies (Summary Last Modified 04/98)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FCCC-96081, NCI-T96-0061H, T96-0061
Phase I Study of Perillyl Alcohol in Patients With Malignancies Who Have Failed Standard Therapy or For Whom No Standard Therapy Exists (Summary Last Modified 06/1999)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-9694, NCI-T96-0062, T96-0062
Phase I Study of Perillyl Alcohol in Patients with Advanced Malignancies (Summary Last Modified 04/2000)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-97022, NCI-T96-0077, T96-0077
Phase I Study of Single Dose Perillyl Alcohol in Women With and Without a History of Breast Cancer (Summary Last Modified 03/2000)
Phase: Phase I
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCF-IRB-1193D, NCI-P97-0089
Start Over